Mesoblast, Inc.   Report issue

For profit Phase 2 Phase 3
Founded: Melbourne Australia (2004)

Organization Overview

First Clinical Trial
2004
NCT00081055
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Mesoblast CMO | Mesoblast, Inc. | Mesoblast International Sarl | Mesoblast International Sàrl | Mesoblast, Ltd., c/o Angioblast Systems, Inc.